Skip to main content
. 2019 Jan-Mar;12(1):8–16. doi: 10.4103/JCAS.JCAS_97_18

Table 2:

LHR in treatment in hidradenitis suppurativa

S/No. Study (reference) Patient no. Laser parameters Treatment sittings Follow-up Outcome Adverse effects
1 Downs et al.[26] 1 Diode 14 J/cm2; 50ms, 6 mm 4 None Decreased erythema and tenderness Pain during treatment
2 Highton et al.[25] 17 IPL (420nm); 7–10 J/ cm2, 30–50 ms 8 12 months Significant improvement of treated site compared to control and maintained in F/U period Erythema posttreatment
3 Mahmoud et al.[28] 17 Nd:YAG; 40–50 J/cm2, 20ms, 10mm (skin types I–III); 25–35 J/ cm2, 35ms, 10mm (skin types IV–VI) 4 2 months Progressive reduction in disease activity; remission maintained in follow-up period 40% patients experienced periprocedural pain
4 Tierney et al.[24] 17 Nd:YAG; 40–50 J/cm2, 20ms, 10mm (skin types I–III); 25–35 J/ cm2, 35ms, 10mm (skin types IV–VI) 3 1 month Statistically significant improvement in HS severity of 65.3% averaged over all body sites treated (LHR + topical antibiotics) compared to control (topical antibiotics) at 3 months Initial worsening of inflammation
5 Koch et al.[23] 1 Alexandrite; 15–22 J/ cm2, 20ms, 15 mm 6 10 months Excellent response
6 Jain et al.[29] 4 Nd:YAG+ CO2 laser 4–5 3 years None showed any recurrence
7 Xu et al.[27] 20 Nd:YAG 2 2 months Significant improvement of treated site compared to control at 2 months; clinicopathologic correlation between disease activity and histological characteristics following laser treatment was also noted Initial worsening of inflammation

HS = hidradenitis suppurativa; IPL = intense pulse light; LHR = laser hair removal; Nd:YAG = neodymium:yttrium aluminum garnet